Bayer Hit by Around $2.5 Billion of Impairments at Ailing Crop Business
08 Août 2023 - 8:43AM
Dow Jones News
By Cecilia Butini
Bayer booked impairments and charges related to its agricultural
business, where lower glyphosate prices weighed, leading to a
widened second-quarter loss, it said Tuesday.
The German pharmaceutical and agricultural company said
impairment losses of 2.30 billion euros ($2.53 billion) dragged
earnings, and posted a net loss for the quarter of EUR1.88 billion.
In the same quarter the previous year, the net loss had been EUR298
million.
Sales were EUR11.04 billion for the period, in line with a
forecast the company gave when it revised its guidance on July 24.
Earnings before interest, taxes, depreciation and amortization
before special items--a key company metric--declined to EUR2.53
billion from EUR3.35 billion the previous year, in line with
company expectations.
Bayer confirmed the lowered guidance it issued on July 24 due to
a significant decline in sales of glyphosate-based products. The
guidance includes projected sales in a range of EUR48.5 billion and
EUR49.5 billion for the full year, meaning a 2% to 3% decline.
The Crop Science agricultural division is seen with a sales
decline of 5%, while sales in the pharmaceutical business are
expected roughly flat compared with the previous year, Bayer
said.
Write to Cecilia Butini at cecilia.butini@wsj.com
(END) Dow Jones Newswires
August 08, 2023 02:28 ET (06:28 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
Bayer Aktiengesellschaft (PK) (USOTC:BAYRY)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Bayer Aktiengesellschaft (PK) (USOTC:BAYRY)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024
Real-Time news about Bayer Aktiengesellschaft (PK) (OTCMarkets): 0 recent articles
Plus d'articles sur Bayer Aktiengesellschaft (PK)